Efficacy and Safety of TKIs' Withdrawal After a Two-step Dose Reduction in Patients With Chronic Myeloid Leukemia

Conditions:   Chronic Myeloid Leukemia, Chronic Phase;   Withdrawal;Drug Interventions:   Drug: Imatinib withdrawal;   Drug: Dasatinib;   Drug: Nilotinib Sponsor:   Masaryk University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials